A carregar...
Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1
AIMS/HYPOTHESIS: Peroxisome proliferator-activated receptor (PPAR) γ agonists are used increasingly in the treatment of type 2 diabetes. In the context of renal disease, PPARγ agonists reduce microalbuminuria in diabetic nephropathy; however, the mechanisms underlying this effect are unknown. Glomer...
Na minha lista:
| Publicado no: | Diabetologia |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7614273/ https://ncbi.nlm.nih.gov/pubmed/19533082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-009-1423-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|